-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Kiora Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q3 2024.
- Kiora Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 4.21M shares, a 434% increase year-over-year.
- Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.84M shares, a 561% increase from 2022.
- Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 732K shares, a 204% increase from 2021.
- Kiora Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 241K shares, a 94.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)